Shares of National Health Investors, Inc. (NYSE:NHI – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the seven brokerages that are covering the company, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1-year price objective among analysts that have covered the stock in the last year is $73.29.
A number of equities research analysts have commented on NHI shares. StockNews.com lowered National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, October 15th. Truist Financial upped their price target on National Health Investors from $65.00 to $78.00 and gave the company a “hold” rating in a research report on Friday, August 30th. Bank of America started coverage on National Health Investors in a research note on Tuesday, September 24th. They set a “buy” rating and a $92.00 target price for the company. Finally, Wells Fargo & Company cut National Health Investors from an “overweight” rating to an “equal weight” rating and raised their target price for the stock from $81.00 to $86.00 in a research note on Tuesday, October 1st.
View Our Latest Analysis on National Health Investors
Institutional Investors Weigh In On National Health Investors
National Health Investors Trading Up 1.3 %
NYSE NHI opened at $78.45 on Thursday. The business’s 50-day moving average price is $80.65 and its two-hundred day moving average price is $72.58. National Health Investors has a 12 month low of $49.25 and a 12 month high of $86.13. The firm has a market capitalization of $3.41 billion, a PE ratio of 26.68, a price-to-earnings-growth ratio of 4.72 and a beta of 1.04. The company has a current ratio of 10.27, a quick ratio of 10.27 and a debt-to-equity ratio of 0.91.
National Health Investors (NYSE:NHI – Get Free Report) last released its quarterly earnings results on Tuesday, August 6th. The real estate investment trust reported $0.81 EPS for the quarter, missing analysts’ consensus estimates of $1.10 by ($0.29). National Health Investors had a net margin of 39.11% and a return on equity of 10.11%. The company had revenue of $84.97 million during the quarter, compared to the consensus estimate of $64.95 million. During the same quarter last year, the firm posted $1.06 EPS. The company’s quarterly revenue was up 9.1% on a year-over-year basis. On average, analysts expect that National Health Investors will post 4.52 EPS for the current year.
National Health Investors Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Shareholders of record on Friday, September 27th will be paid a $0.90 dividend. The ex-dividend date is Friday, September 27th. This represents a $3.60 dividend on an annualized basis and a yield of 4.59%. National Health Investors’s dividend payout ratio (DPR) is presently 122.45%.
About National Health Investors
Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
See Also
- Five stocks we like better than National Health Investors
- Canada Bond Market Holiday: How to Invest and Trade
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- What is a Special Dividend?
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.